Fig. 6
Hepatic alpha-smooth muscle actin (α-SMA) expression. α-SMA immunostaining in control mice (a) and mice receiving MC 400 mg/kg (b). α-SMA immunoreactivity in CCl4-intoxicated mice (c) and mice secondary treated by MC at doses of 50 mg/kg (d), 200 mg/kg (e) and 400 mg/kg (f) and silymarin at dose of 400 mg/kg (g). Original magnification 400x. Representative results from 5 similarly treated mice. Measurement of the α-SMA immunostaining intensity (h). Means sharing the same letter are not significantly different from each other (P < 0.05)